We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+14.49%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$15.1B
AUM Growth
+$2.22B
Cap. Flow
+$548M
Cap. Flow %
3.64%
Top 10 Hldgs %
28.62%
Holding
2,384
New
671
Increased
477
Reduced
577
Closed
562

Sector Composition

Rank Sector Weight
1 Industrials 11.79%
2 Technology 9.94%
3 Financials 9.21%
4 Consumer Discretionary 9.02%
5 Healthcare 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SID icon
1651
Companhia Siderúrgica Nacional
SID
$1.25B
$67.6K ﹤0.01%
17,200
-153,900
-90% -$445K
GMBL
1652
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
$66K ﹤0.01%
+16,700
New +$309K
EBS icon
1653
Emergent Biosolutions
EBS
$274M
$65.3K ﹤0.01%
+27,200
New +$63.9K
MNOV icon
1654
MediciNova
MNOV
$66.9M
$62.4K ﹤0.01%
41,600
-600
-1% -$1.08K
RTX icon
1655
RTX Corp
RTX
$301B
$62.3K ﹤0.01%
741
-23,230
-97% -$1.84M
KEEL
1656
Keel Infrastructure Corp
KEEL
$2.31B
$62.3K ﹤0.01%
+21,400
New +$34.4K
MAMA icon
1657
Mama's Creations
MAMA
$851M
$60.9K ﹤0.01%
+12,395
New +$48.9K
ASTS icon
1658
AST SpaceMobile
ASTS
$20.1B
$60.3K ﹤0.01%
10,000
-9,400
-48% -$40.8K
UPLD icon
1659
Upland Software
UPLD
$12.6M
$59.7K ﹤0.01%
+1,411
New +$61K
AACG
1660
ATA Creativity
AACG
$38.9M
$59.6K ﹤0.01%
51,400
-600
-1% -$576
INFN
1661
DELISTED
Infinera Corporation Common Stock
INFN
$58.3K ﹤0.01%
+12,268
New +$48.3K
ANY icon
1662
Sphere 3D
ANY
$17.1M
$56.1K ﹤0.01%
+1,690
New +$23K
PL icon
1663
Planet Labs
PL
$8.1B
$54.6K ﹤0.01%
+22,100
New +$52.3K
XELA
1664
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$52.8K ﹤0.01%
15,700
+500
+3% +$1.66K
ORN icon
1665
Orion Group Holdings
ORN
$410M
$52.7K ﹤0.01%
+10,670
New +$52.5K
BIOR
1666
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$52.2K ﹤0.01%
3,870
-240
-6% -$3.89K
DOUG icon
1667
Douglas Elliman
DOUG
$163M
$52.2K ﹤0.01%
17,700
-7,200
-29% -$15.1K
MPU icon
1668
Mega Matrix
MPU
$14M
$50.5K ﹤0.01%
35,800
-1,100
-3% -$1.18K
PMCB icon
1669
PharmaCyte Biotech
PMCB
$6.34M
$50.1K ﹤0.01%
23,200
-100
-0.4% -$217
NVAX icon
1670
Novavax
NVAX
$1.27B
$49.9K ﹤0.01%
10,395
-73,346
-88% -$449K
NNBR icon
1671
NN Inc
NNBR
$298M
$49.1K ﹤0.01%
+12,263
New +$29.2K
CLOV icon
1672
Clover Health Investments
CLOV
$2.45B
$47.5K ﹤0.01%
+49,900
New +$49K
TPST icon
1673
Tempest Therapeutics
TPST
$14.4M
$45.3K ﹤0.01%
+792
New +$37.5K
IFRX icon
1674
InflaRx
IFRX
$253M
$45.2K ﹤0.01%
27,700
-343,522
-93% -$589K
API
1675
Agora
API
$351M
$45K ﹤0.01%
+17,100
New +$47.8K

Similar funds

Schonfeld Strategic Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Schonfeld Strategic Advisors held 2,384 positions worth $15.1B, up 17% from $12.9B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Schonfeld Strategic Advisors deployed $548M of net new capital in Q4 2023, opening 671 new positions and adding to 477 existing holdings. Its largest new stake was Equifax: 214,316 shares worth $53M.

By sector, the portfolio is most concentrated in Industrials at 12% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Union Pacific, an estimated $115M trimmed.

  • Schonfeld Strategic Advisors's largest Q4 2023 buy was Equifax: 214,316 shares worth $53M.
  • Schonfeld Strategic Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.67B increase.
  • Schonfeld Strategic Advisors's biggest Q4 2023 reduction was Union Pacific, cutting an estimated $115M.
  • Schonfeld Strategic Advisors fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2023, selling an estimated $94.5M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 29% of its $15.1B portfolio in Q4 2023.
  • Schonfeld Strategic Advisors opened 671 new positions and closed 562 in Q4 2023.
  • Schonfeld Strategic Advisors's portfolio value rose 17% quarter-over-quarter to $15.1B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.